Cibus’ (CBUS) “Buy” Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Cibus (NASDAQ:CBUS) in a research report released on Friday,Benzinga reports. The firm currently has a $25.00 target price on the stock. HC Wainwright also issued estimates for Cibus’ Q1 2025 earnings at ($0.66) EPS, Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Separately, Canaccord Genuity Group reduced their price target on Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd.

Cibus Price Performance

Shares of CBUS opened at $2.05 on Friday. The company has a market cap of $54.23 million, a P/E ratio of -0.09 and a beta of 2.04. The stock has a fifty day moving average price of $2.33 and a 200 day moving average price of $3.31. Cibus has a 12 month low of $1.80 and a 12 month high of $23.18.

Cibus (NASDAQ:CBUS) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing analysts’ consensus estimates of ($0.68) by ($0.19). The company had revenue of $1.21 million for the quarter, compared to the consensus estimate of $1.13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. As a group, research analysts anticipate that Cibus will post -2.96 earnings per share for the current year.

Institutional Trading of Cibus

Institutional investors have recently modified their holdings of the company. IFP Advisors Inc acquired a new stake in shares of Cibus in the fourth quarter valued at $36,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Cibus in the third quarter valued at $44,000. Virtu Financial LLC acquired a new stake in shares of Cibus in the third quarter valued at $48,000. Sei Investments Co. acquired a new stake in shares of Cibus in the fourth quarter valued at $49,000. Finally, HighTower Advisors LLC lifted its holdings in shares of Cibus by 20.6% in the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after buying an additional 2,750 shares during the period. Institutional investors and hedge funds own 33.81% of the company’s stock.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.